AU2001261133A1 - Detection of antibodies to gangliosides - Google Patents

Detection of antibodies to gangliosides

Info

Publication number
AU2001261133A1
AU2001261133A1 AU2001261133A AU6113301A AU2001261133A1 AU 2001261133 A1 AU2001261133 A1 AU 2001261133A1 AU 2001261133 A AU2001261133 A AU 2001261133A AU 6113301 A AU6113301 A AU 6113301A AU 2001261133 A1 AU2001261133 A1 AU 2001261133A1
Authority
AU
Australia
Prior art keywords
gangliosides
antibodies
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261133A
Other languages
English (en)
Inventor
Louis P. Kertiles
Normand J. Robichaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Elan Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharmaceuticals LLC filed Critical Elan Pharmaceuticals LLC
Publication of AU2001261133A1 publication Critical patent/AU2001261133A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08Sphingolipids
    • G01N2405/10Glycosphingolipids, e.g. cerebrosides, gangliosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001261133A 2000-05-05 2001-05-03 Detection of antibodies to gangliosides Abandoned AU2001261133A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/565,837 US6824999B1 (en) 2000-05-05 2000-05-05 Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups
US09/565,837 2000-05-05
PCT/US2001/014185 WO2001086295A2 (en) 2000-05-05 2001-05-03 Detection of antibodies to gangliosides

Publications (1)

Publication Number Publication Date
AU2001261133A1 true AU2001261133A1 (en) 2001-11-20

Family

ID=24260311

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261133A Abandoned AU2001261133A1 (en) 2000-05-05 2001-05-03 Detection of antibodies to gangliosides

Country Status (5)

Country Link
US (2) US6824999B1 (ja)
JP (1) JP2004501359A (ja)
AU (1) AU2001261133A1 (ja)
CA (1) CA2378172C (ja)
WO (1) WO2001086295A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824999B1 (en) * 2000-05-05 2004-11-30 Athena Diagnostics, Inc. Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups
US6777193B1 (en) * 2000-08-04 2004-08-17 Escuela Nacional De Ciencias Biologicas, Del Instituto Politecnico Nacional Methods for diagnostic and/or treatment of antiphospholipids antibodies-related diseases, and devices
JP2009031001A (ja) * 2007-07-24 2009-02-12 Dainichiseika Color & Chem Mfg Co Ltd IgA抗体測定方法
CA2772032C (en) * 2009-09-02 2017-06-20 The Washington University Antibodies to disulfated heparin disaccharide in the diagnosis of neuropathy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD285099A5 (de) * 1989-06-20 1990-12-05 Klinikum Berlin Buch,Dd Verfahren zur aktivierung von polystyren-festkoerperflaechen
AU2484892A (en) 1991-08-09 1993-03-02 Washington University Autoantibodies and their targets in the diagnosis of peripheral neuropathies
US5985578A (en) * 1991-08-09 1999-11-16 Washington University Autoantibodies and their targets in the diagnosis of peripheral neuropathies
JPH0968532A (ja) * 1995-08-31 1997-03-11 Toppan Printing Co Ltd マイクロプレート
SE9601817D0 (sv) 1996-05-13 1996-05-13 Karsten Buschard Novel glycolipid complexex and their uses
US6528272B2 (en) 1997-02-10 2003-03-04 The Johns Hopkins University Receptor-based assays for pathogens
US6077681A (en) * 1997-06-30 2000-06-20 Washington University Diagnosis of motor neuropathy by detection of antibodies
JPH11142404A (ja) * 1997-11-07 1999-05-28 Otsuka Pharmaceut Co Ltd メニエール病特異抗原及びその医学的用途
US6228598B1 (en) * 1998-10-02 2001-05-08 Washington University Antibodies to heparan sulfate glycosaminoglycans in the diagnosis of polyneuropathies
US6824999B1 (en) * 2000-05-05 2004-11-30 Athena Diagnostics, Inc. Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups
US6599756B1 (en) * 2000-07-27 2003-07-29 Athena Diagnostics, Inc. Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups
US6448023B1 (en) 2000-09-14 2002-09-10 Atairgin Technologies, Inc. Enzyme method for detecting sphingosine-1-phosphate (S1P)

Also Published As

Publication number Publication date
CA2378172C (en) 2009-09-08
US6824999B1 (en) 2004-11-30
CA2378172A1 (en) 2001-11-15
WO2001086295A2 (en) 2001-11-15
US20050233384A1 (en) 2005-10-20
JP2004501359A (ja) 2004-01-15
WO2001086295A3 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
EP2270052B8 (en) Antibodies to OPGL
HK1061403A1 (en) ANTIBODIES TO HUMAN IL-1ß
AU2000269903A1 (en) Mechanical connection of panels
AU3041100A (en) Binding of antibody fragments to solid supports
AU1290001A (en) Antibodies
EP1130098A3 (en) Mammalian osteoregulins
AU2001236916A1 (en) Techniques to facilitate shopping for projects
GB9814383D0 (en) Improvements relating to antibodies
AU2001267428A1 (en) Direct detection of individual molecules
EP1346222A4 (en) FIXING A SECOND HARMONIC-ACTIVE FUNCTIONAL GROUP TO MOLECULE DETECTION MOLECULES AT INTERFACE LEVELS
AU2001229530A1 (en) Detection of fermentation-related microorganisms
AU2001276874A1 (en) Continuous preparation of polycarbonate
AUPQ262299A0 (en) Detection of inclusions in glass
AU2001261133A1 (en) Detection of antibodies to gangliosides
AU2002365894A1 (en) Antibodies to magmas and uses thereof
AU2001280436A1 (en) Process to increase protein stability
AU2002226059A1 (en) Improved compositions and methods for producing antibodies to low molecular weight analytes
AUPP385598A0 (en) Purification of antibodies
AU2001276523A1 (en) Aspiration of samples
AUPR197000A0 (en) Synthesis of small particles
AU2001271033A1 (en) Means of assaying immune function
AU2002222203A1 (en) Coupling signals to flowlines
AU1917300A (en) Improved specificity in the detection of anti-rubella igm antibodies
AU2001274855A1 (en) Detection of antibodies to squalene in serum
AU2001246862A1 (en) Method of detecting cancer